JP2023553532A5 - - Google Patents
Info
- Publication number
- JP2023553532A5 JP2023553532A5 JP2023560239A JP2023560239A JP2023553532A5 JP 2023553532 A5 JP2023553532 A5 JP 2023553532A5 JP 2023560239 A JP2023560239 A JP 2023560239A JP 2023560239 A JP2023560239 A JP 2023560239A JP 2023553532 A5 JP2023553532 A5 JP 2023553532A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124665P | 2020-12-11 | 2020-12-11 | |
| US63/124,665 | 2020-12-11 | ||
| US202163214718P | 2021-06-24 | 2021-06-24 | |
| US63/214,718 | 2021-06-24 | ||
| US202163253012P | 2021-10-06 | 2021-10-06 | |
| US63/253,012 | 2021-10-06 | ||
| US202163277561P | 2021-11-09 | 2021-11-09 | |
| US63/277,561 | 2021-11-09 | ||
| PCT/US2021/062912 WO2022125962A1 (en) | 2020-12-11 | 2021-12-10 | Combination therapies for the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553532A JP2023553532A (ja) | 2023-12-21 |
| JP2023553532A5 true JP2023553532A5 (https=) | 2024-12-17 |
| JPWO2022125962A5 JPWO2022125962A5 (https=) | 2024-12-17 |
Family
ID=81974006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560239A Pending JP2023553532A (ja) | 2020-12-11 | 2021-12-10 | 癌の処置のための併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240050441A1 (https=) |
| EP (1) | EP4259147A4 (https=) |
| JP (1) | JP2023553532A (https=) |
| KR (1) | KR20230154793A (https=) |
| AU (1) | AU2021396395A1 (https=) |
| CA (1) | CA3201657A1 (https=) |
| WO (1) | WO2022125962A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12122787B2 (en) | 2019-09-20 | 2024-10-22 | Shanghai Jemincare Pharmaceuticals Co., Ltd | Fused pyridone compound, and preparation method therefor and use thereof |
| WO2022125971A1 (en) * | 2020-12-11 | 2022-06-16 | Erasca, Inc. | Combination therapies for the treatment of cancer |
| US20240293422A1 (en) * | 2021-06-24 | 2024-09-05 | Erasca, Inc. | Shp2 and cdk4/6 inhibitors combination therapies for the treatment of cancer |
| WO2023059771A1 (en) * | 2021-10-06 | 2023-04-13 | Erasca, Inc. | Uses of tri-substituted heteroaryl derivatives as src homology-2 phosphatase inhibitors |
| WO2025226830A1 (en) * | 2024-04-23 | 2025-10-30 | Erasca, Inc. | Shp2 and egfr inhibitors for the treatment of chordoma |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2601892C2 (ru) * | 2008-03-06 | 2016-11-10 | Дженентек, Инк. | Комбинированная терапия антагонистами с-мет и egfr |
| US8828391B2 (en) * | 2011-05-17 | 2014-09-09 | Boehringer Ingelheim International Gmbh | Method for EGFR directed combination treatment of non-small cell lung cancer |
| US20150273057A1 (en) * | 2012-10-25 | 2015-10-01 | Glaxosmithkline Llc | Combination |
| US20140308274A1 (en) * | 2013-03-15 | 2014-10-16 | Mirna Therapeutics, Inc. | Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitors |
| JP7542538B2 (ja) * | 2018-09-18 | 2024-08-30 | ニカング セラピューティクス， インコーポレイテッド | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての縮合三環式環誘導体 |
| KR20210144844A (ko) * | 2019-03-29 | 2021-11-30 | 아스트라제네카 아베 | 비-소세포 폐암의 치료에 사용하기 위한 오시머티닙 |
| EP4076667A1 (en) * | 2019-12-20 | 2022-10-26 | Erasca, Inc. | Tricyclic pyridones and pyrimidones |
| US20210292330A1 (en) * | 2020-02-28 | 2021-09-23 | Erasca, Inc. | Pyrrolidine-fused heterocycles |
-
2021
- 2021-12-10 JP JP2023560239A patent/JP2023553532A/ja active Pending
- 2021-12-10 CA CA3201657A patent/CA3201657A1/en active Pending
- 2021-12-10 WO PCT/US2021/062912 patent/WO2022125962A1/en not_active Ceased
- 2021-12-10 AU AU2021396395A patent/AU2021396395A1/en not_active Abandoned
- 2021-12-10 US US18/256,089 patent/US20240050441A1/en active Pending
- 2021-12-10 EP EP21904509.3A patent/EP4259147A4/en not_active Withdrawn
- 2021-12-10 KR KR1020237023446A patent/KR20230154793A/ko not_active Abandoned